Ranked by engagement
Top topics — this year page 11
Ranked by replies, likes and views over this year, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,076 topics · page 11 of 14
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Packaging that arrived damaged: documenting it properly — a second dataset
Posting this under the heading it deserves: Packaging that arrived damaged: documenting it properly — a second dataset Everything below is what sits behind that. A logistics question, since the answers here…
|
+68 | 73 | 20k | 4mo |
|
Revisiting: Liver enzymes drifting down and what that usually means
On the subject in the title: Revisiting: Liver enzymes drifting down and what that usually means Working notes rather than a conclusion. General question, not a request for advice about my own care — I know…
|
+55 | 61 | 39k | 3h |
|
Designing a personal experiment that could change your mind — one year on
Designing a personal experiment that could change your mind — one year on — setting out what I have, and where I think it stops being reliable. Session topic: STEP 4 ( JAMA , 2021). Please read it before…
|
+74 | 80 | 17k | 2d |
|
What to bring: records that a clinician can actually use — a second dataset
What to bring: records that a clinician can actually use — a second dataset I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather than…
|
+80 | 86 | 5.6k | 3h |
|
Pinch or no pinch, and how needle length changes the answer — the long version
On the subject in the title: Pinch or no pinch, and how needle length changes the answer — the long version Working notes rather than a conclusion. I have read the maintained page on this and I still have a…
|
+75 | 79 | 1.5k | 1mo |
|
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. A question about technique rather than about dose. I…
|
+63 | 68 | 35k | 1d |
|
Prescription requirements and telehealth models — a second dataset
On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+87 | 94 | 1.1k | 21d |
|
Pinch or no pinch, and how needle length changes the answer — what changed since
Posting this under the heading it deserves: Pinch or no pinch, and how needle length changes the answer — what changed since Everything below is what sits behind that. I have read the maintained page on this…
|
+58 | 62 | 16k | 1d |
|
Why catalogue breadth is not evidence of anything — what changed since
Asking directly, because I could not find a straight answer: Why catalogue breadth is not evidence of anything — what changed since Session topic: SURMOUNT-1 ( N Engl J Med , 2022). Please read it before…
|
+62 | 66 | 26k | 10mo |
|
Bug report: the reconstitution calculator and a rounding edge case
Bug report: the reconstitution calculator and a rounding edge case — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
|
+68 | 72 | 28k | 4mo |
|
Does a peptide degrade silently, with no visual change?
Does a peptide degrade silently, with no visual change? I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this and I still have a…
|
+73 | 79 | 1.3k | 1d |
|
Why the absence of controlled human data on BPC-157 matters more than people admit
Why the absence of controlled human data on BPC-157 matters more than people admit — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing STEP 8 ( JAMA , 2022) with…
|
+60 | 66 | 16k | 1d |
|
Follow-up: Comparing two chromatograms from different laboratories, properly
Comparing two chromatograms from different laboratories, properly — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it…
|
+62 | 67 | 12k | 9h |
|
A single out-of-range value on an otherwise normal panel
Posting this under the heading it deserves: A single out-of-range value on an otherwise normal panel Everything below is what sits behind that. General question, not a request for advice about my own care — I…
|
+70 | 75 | 20k | 6d |
|
Revisiting: Drawing up with one needle and injecting with another
Revisiting: Drawing up with one needle and injecting with another Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because I have…
|
+76 | 83 | 1.1k | 4mo |
|
Search filters: what is missing
Search filters: what is missing — setting out what I have, and where I think it stops being reliable. Nominating something for promotion into the documentation commons. The topic in question keeps being…
|
+74 | 84 | 15k | 3d |
|
Fatigue in the first month: how much is the drug and how much is intake — what changed since
Fatigue in the first month: how much is the drug and how much is intake — what changed since Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page…
|
+77 | 82 | 1.2k | 11mo |
|
Semaglutide versus liraglutide head to head: reading STEP 8 carefully
On the subject in the title: Semaglutide versus liraglutide head to head: reading STEP 8 carefully Working notes rather than a conclusion. I have seen PIONEER 6 ( N Engl J Med , 2019) cited in support of a…
|
+72 | 81 | 1.5k | 9mo |
|
Follow-up: Bug report: the reconstitution calculator and a rounding edge case
On the subject in the title: Bug report: the reconstitution calculator and a rounding edge case Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
+58 | 63 | 24k | 5mo |
|
Subgroup analyses: pre-specified versus discovered — a second dataset
On the subject in the title: Subgroup analyses: pre-specified versus discovered — a second dataset Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-4 ( Lancet ,…
|
+71 | 79 | 906 | 3mo |
|
Sleep quality changes during weight loss — what changed since
Sleep quality changes during weight loss — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+68 | 74 | 10k | 8mo |
|
Nausea profile of amylin analogues compared with GLP-1 agonists
Nausea profile of amylin analogues compared with GLP-1 agonists Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURPASS-4 ( Lancet , 2021). Please read it…
|
+70 | 76 | 3k | 4mo |
|
Prior authorisation: what the criteria usually require — a second dataset
Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. A coverage question with the paperwork detail…
|
+67 | 74 | 19k | 21h |
|
Completing a dose with a second syringe, and the dead-volume arithmetic
Posting this under the heading it deserves: Completing a dose with a second syringe, and the dead-volume arithmetic Everything below is what sits behind that. I have read the maintained page on this and I…
|
+65 | 76 | 7.4k | 1d |
|
Cost per delivered dose, which is the number that matters
Cost per delivered dose, which is the number that matters — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what…
|
+54 | 59 | 30k | 4mo |
|
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a…
|
+64 | 69 | 15k | 7mo |
|
What pooling buys you and what it destroys
The question in the title: What pooling buys you and what it destroys I will give what I have already checked below so nobody repeats it. Comparing SURMOUNT-2 ( Lancet , 2023) with LEADER ( N Engl J Med ,…
|
+74 | 83 | 6.6k | 8mo |
|
Reporting a disappointing outcome, and why it belongs here
Reporting a disappointing outcome, and why it belongs here Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a number…
|
+21 | 29 | 62k | 10mo |
|
A widely repeated interaction claim that turns out to be unsupported
On the subject in the title: A widely repeated interaction claim that turns out to be unsupported Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
|
+47 | 51 | 37k | 3mo |
|
Storing lyophilised material long term: what governs the shelf life
On the subject in the title: Storing lyophilised material long term: what governs the shelf life Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
|
+83 | 90 | 1k | 5mo |